PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 5, 2020

Primary Completion Date

November 2, 2023

Study Completion Date

November 2, 2023

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Computed Tomography

Undergo CT

DRUG

Gallium Ga 68 Gozetotide

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography

Undergo PET

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04310540 - PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer | Biotech Hunter | Biotech Hunter